Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction
The Visceral Adiposity Index (VAI) has recently proven to be an indicator of adipose distribution and function that indirectly expresses cardiometabolic risk. In addition, VAI has been proposed as a useful tool for early detection of a condition of cardiometabolic risk before it develops into an ove...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Hindawi Publishing Corporation
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009335/ |
| id |
pubmed-4009335 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-40093352014-05-14 Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction Amato, Marco Calogero Giordano, Carla Review Article The Visceral Adiposity Index (VAI) has recently proven to be an indicator of adipose distribution and function that indirectly expresses cardiometabolic risk. In addition, VAI has been proposed as a useful tool for early detection of a condition of cardiometabolic risk before it develops into an overt metabolic syndrome. The application of the VAI in particular populations of patients (women with polycystic ovary syndrome, patients with acromegaly, patients with NAFLD/NASH, patients with HCV hepatitis, patients with type 2 diabetes, and general population) has produced interesting results, which have led to the hypothesis that the VAI could be considered a marker of adipose tissue dysfunction. Unfortunately, in some cases, on the same patient population, there is conflicting evidence. We think that this could be mainly due to a lack of knowledge of the application limits of the index, on the part of various authors, and to having applied the VAI in non-Caucasian populations. Future prospective studies could certainly better define the possible usefulness of the VAI as a predictor of cardiometabolic risk. Hindawi Publishing Corporation 2014 2014-04-14 /pmc/articles/PMC4009335/ /pubmed/24829577 http://dx.doi.org/10.1155/2014/730827 Text en Copyright © 2014 M. C. Amato and C. Giordano. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Amato, Marco Calogero Giordano, Carla |
| spellingShingle |
Amato, Marco Calogero Giordano, Carla Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction |
| author_facet |
Amato, Marco Calogero Giordano, Carla |
| author_sort |
Amato, Marco Calogero |
| title |
Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction |
| title_short |
Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction |
| title_full |
Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction |
| title_fullStr |
Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction |
| title_full_unstemmed |
Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction |
| title_sort |
visceral adiposity index: an indicator of adipose tissue dysfunction |
| description |
The Visceral Adiposity Index (VAI) has recently proven to be an indicator of adipose distribution and function that indirectly expresses cardiometabolic risk. In addition, VAI has been proposed as a useful tool for early detection of a condition of cardiometabolic risk before it develops into an overt metabolic syndrome. The application of the VAI in particular populations of patients (women with polycystic ovary syndrome, patients with acromegaly, patients with NAFLD/NASH, patients with HCV hepatitis, patients with type 2 diabetes, and general population) has produced interesting results, which have led to the hypothesis that the VAI could be considered a marker of adipose tissue dysfunction. Unfortunately, in some cases, on the same patient population, there is conflicting evidence. We think that this could be mainly due to a lack of knowledge of the application limits of the index, on the part of various authors, and to having applied the VAI in non-Caucasian populations. Future prospective studies could certainly better define the possible usefulness of the VAI as a predictor of cardiometabolic risk. |
| publisher |
Hindawi Publishing Corporation |
| publishDate |
2014 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009335/ |
| _version_ |
1612085168218046464 |